Skip to main content
Clinical Trials/CTRI/2022/08/044691
CTRI/2022/08/044691
Not yet recruiting
Phase 4

Randomised double blinded prospective study to compare the effects of 0.75% Ropivacaine heavy and 0.5% Bupivacaine heavy in subarachnoid block for caesarean delivery in obstetric patients

Mytily0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Sponsor
Mytily
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Mytily

Eligibility Criteria

Inclusion Criteria

  • Obstetric patients coming for elective caesarean section
  • Age group of 20\-40 years
  • ASA 1 \& ASA 2 patients
  • Full term pregnant patients
  • Patients with Single live intrauterine fetus

Exclusion Criteria

  • 1\.Patients who refuse
  • 2\.Emergency surgeries
  • 3\.Age group \<20 or \>40 years of age
  • 4\.ASA 3 \& ASA 4 patients
  • 5\.Pre term patients
  • 6\.Multiple pregnancy (twin or more gestation)
  • 7\.Associated comorbid conditions( PIH, GDM, Anaemia, Heart disease)
  • 8\.Bleeding diathesis patients
  • 9\.Fetal indication for caesarean delivery

Outcomes

Primary Outcomes

Not specified

Similar Trials